Cargando…
Endothelial progenitor cells display clonal restriction in multiple myeloma
BACKGROUND: In multiple myeloma (MM), increased neoangiogenesis contributes to tumor growth and disease progression. Increased levels of endothelial progenitor cells (EPCs) contribute to neoangiogenesis in MM, and, importantly, covary with disease activity and response to treatment. In order to unde...
Autores principales: | Braunstein, Marc, Özçelik, Tayfun, Bağişlar, Sevgi, Vakil, Varsha, Smith, Eric LP, Dai, Kezhi, Akyerli, Cemaliye B, Batuman, Olcay A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557670/ https://www.ncbi.nlm.nih.gov/pubmed/16790068 http://dx.doi.org/10.1186/1471-2407-6-161 |
Ejemplares similares
-
Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy
por: Yun, Charles, et al.
Publicado: (2015) -
Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer
por: Keskin Karakoyun, Hilal, et al.
Publicado: (2023) -
Clonal and Scalable Endothelial Progenitor Cell Lines from Human Pluripotent Stem Cells
por: Lee, Jieun, et al.
Publicado: (2023) -
Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma
por: Bianchi, Giada, et al.
Publicado: (2014) -
Extreme Clonality in Lymphoblastoid Cell Lines with Implications for Allele Specific Expression Analyses
por: Plagnol, Vincent, et al.
Publicado: (2008)